https://www.nrgtherapeutics.com/wp-content/uploads/2026/08/admin_biospace.jpg400605Webadmhttps://www.nrgtherapeutics.com/wp-content/uploads/2026/07/NRG_Logo.pngWebadm2022-11-09 08:03:432026-08-14 16:09:06NRG Therapeutics Scores $18M to Target Mitochondrial Dysfunction in Parkinson’s, ALS
Following the path to a new drug, together